The IDIAP Jordi Gol ethics committee approves the pilot test to open Girona
The test is waiting for the evolution of Easter infections
The Obrir Girona pilot test will begin once the contagions that could have occurred during the Easter holidays stabilize. The project promoted by the Blockchain Center of Catalonia (CBCat) has already obtained the approval of the Research Ethics Committee of the Jordi Gol University Institute for Research in Primary Care (IDIAP). The promoters together with a group of researchers from IDIAP had to develop a research project to analyze the health measures that had to be applied before starting to do activities with the public using the digital pass.
In addition, this February, 39 pharmacies in Girona, Salt and Sarrià de Ter were trained so that they can make a pot of antigens and record the result in the virtual pass or include the vaccination certificate. People vaccinated or who have a pot with a negative result will be accredited as MBCC (Very Low Contagious Capacity). With this accreditation they will be able to access events such as concerts, plays or go public to sports competitions. The activities included in this pilot test will be announced with the start of the project. Those interested in participating will need to download the free mobile application AOKpass. This application will serve as a digital pass where pharmacies will have to include the results of the Rapid Antigen Pots (TAR) or the vaccination certificate. The application is supported by the International Chamber of Commerce and is under the umbrella of the Good Health Pass Collaborative, a global initiative that works to make digital accreditations. With this application, anyone can check the health status of another. In order to carry out this project, however, a group of researchers from IDIAP Jordi Gol, together with the Blockchain Center of Catalonia (CBCat) and the Girona College of Pharmacists, had to draw up a research protocol. It details the planned health measures and their organization. Through this protocol, it will be possible to analyze the effect of the initiative on the incidence of covid-19 cases in real conditions. Now, the Research Ethics Committee has given its approval to the project and the final stretch of the process is already in place to start putting it into practice.